SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000325
Filing Date
2021-01-06
Accepted
2021-01-06 07:00:28
Documents
12
Period of Report
2021-01-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K FOR 2021 GUIDANCE PR crnx-8k_20210106.htm   iXBRL 8-K 54997
  Complete submission text file 0001564590-21-000325.txt   192511

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210106.xsd EX-101.SCH 5780
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210106_lab.xml EX-101.LAB 20227
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210106_pre.xml EX-101.PRE 12087
5 EXTRACTED XBRL INSTANCE DOCUMENT crnx-8k_20210106_htm.xml XML 3695
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 21508980
SIC: 2834 Pharmaceutical Preparations